Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.

× No keyword cloud information.

10 in total

1. Prolonged survival and improved glycemia in BioBreeding diabetic rats after early sustained exposure to glucagon-like peptide 1.

Authors: Ofer Yanay; Daniel Moralejo; Kelly Kernan; Margaret Brzezinski; Jessica M Fuller; Randall W Barton; Ake Lernmark; William R Osborne
Journal: J Gene Med Date: 2010-06 Impact factor: 4.565

2. New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins.

Authors: Baptist Gallwitz
Journal: Rev Diabet Stud Date: 2005-08-10

3. Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.

Authors: Barbara Leiting; KellyAnn D Pryor; Joseph K Wu; Frank Marsilio; Reshma A Patel; Charles S Craik; Jonathan A Ellman; Richard T Cummings; Nancy A Thornberry
Journal: Biochem J Date: 2003-04-15 Impact factor: 3.857

4. Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

Authors: Belinda Gier; Aleksey V Matveyenko; David Kirakossian; David Dawson; Sarah M Dry; Peter C Butler
Journal: Diabetes Date: 2012-01-20 Impact factor: 9.461

5. Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties.

Authors: Flávio Reis; Edite Teixeira de Lemos; Cristina Mega; Helena Vala; Paulo Rodrigues-Santos; Jorge Oliveira; Frederico Teixeira; Rosa Fernandes
Journal: Diabetol Metab Syndr Date: 2014-03-20 Impact factor: 3.320

6. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Reduces Aortic Damage from Hypercholesterolaemia in Apolipoprotein E-Deficient Mice.

Authors: Ying Zhang; Nan Wang; Liyue Zhu; Yingshu Liu; Zuowei Pei; Guan Wang; Lin Luo; Hongyang Liu
Journal: Biomed Hub Date: 2017-05-20

7. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.

Authors: Aleksey V Matveyenko; Sarah Dry; Heather I Cox; Artemis Moshtaghian; Tatyana Gurlo; Ryan Galasso; Alexandra E Butler; Peter C Butler
Journal: Diabetes Date: 2009-04-29 Impact factor: 9.461

Review 8. Review of sitagliptin phosphate: a novel treatment for type 2 diabetes.

Authors: Baptist Gallwitz
Journal: Vasc Health Risk Manag Date: 2007

9. The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice.

Authors: Jingjing Li; Meiping Guan; Chenzhong Li; Fuping Lyv; Yanmei Zeng; Zongji Zheng; Chengzhi Wang; Yaoming Xue
Journal: Int J Mol Sci Date: 2014-06-26 Impact factor: 5.923

10. Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice.

Authors: Gwon Soo Jung; Jae Han Jeon; Mi Sun Choe; Sung Woo Kim; In Kyu Lee; Mi Kyung Kim; Keun Gyu Park
Journal: Diabetes Metab J Date: 2016-04-21 Impact factor: 5.376

10 in total